# Himax Technologies, Inc.: financial statements, quarterly

HIMX · Nasdaq · CIK 1342338 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/himx.md) · [Financials](/companies/himx/financials.md) · [Filings](/companies/himx/filings.md) · [Insiders](/companies/himx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/himx/financials.md?period=annual).

## Balance sheet

| Line item | Unit | FY2014 (2014-12-31) | FY2015 (2015-12-31) | FY2016 (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [185](/filings/0001144204-18-017279.md) | [130](/filings/0001144204-18-017279.md) | [184](/filings/0001144204-18-017279.md) | [138](/filings/0001144204-18-017279.md) | [106](/filings/0001410578-22-000463.md) | [101](/filings/0001410578-23-000618.md) | [185](/filings/0001104659-24-042156.md) | [336](/filings/0001410578-25-000623.md) | [222](/filings/0001104659-26-035507.md) | [192](/filings/0001104659-26-035507.md) | [218](/filings/0001104659-26-035507.md) | [258](/filings/0001104659-26-035507.md) |
| Current assets | $m | [730](/filings/0001144204-16-093972.md) | [698](/filings/0001144204-17-020070.md) | [703](/filings/0001144204-18-017279.md) | [661](/filings/0001144204-18-017279.md) | [654](/filings/0001104659-20-037959.md) | [605](/filings/0001104659-21-044259.md) | [694](/filings/0001410578-22-000463.md) | [1,193](/filings/0001410578-23-000618.md) | [1,337](/filings/0001104659-24-042156.md) | [1,201](/filings/0001410578-25-000623.md) | [1,168](/filings/0001104659-26-035507.md) | [1,265](/filings/0001104659-26-035507.md) |
| Total assets | $m | [833](/filings/0001144204-16-093972.md) | [802](/filings/0001144204-17-020070.md) | [800](/filings/0001144204-18-017279.md) | [802](/filings/0001144204-18-017279.md) | [837](/filings/0001104659-20-037959.md) | [818](/filings/0001104659-21-044259.md) | [910](/filings/0001410578-22-000463.md) | [1,603](/filings/0001410578-23-000618.md) | [1,702](/filings/0001104659-24-042156.md) | [1,643](/filings/0001410578-25-000623.md) | [1,640](/filings/0001104659-26-035507.md) | [1,735](/filings/0001104659-26-035507.md) |
| Current liabilities | $m | [355](/filings/0001144204-16-093972.md) | [353](/filings/0001144204-17-020070.md) | [325](/filings/0001144204-18-017279.md) | [337](/filings/0001144204-18-017279.md) | [391](/filings/0001104659-20-037959.md) | [381](/filings/0001104659-21-044259.md) | [352](/filings/0001410578-22-000463.md) | [601](/filings/0001410578-23-000618.md) | [694](/filings/0001104659-24-042156.md) | [709](/filings/0001410578-25-000623.md) | [707](/filings/0001104659-26-035507.md) | [800](/filings/0001104659-26-035507.md) |
| Total liabilities | $m | [361](/filings/0001144204-16-093972.md) | [357](/filings/0001144204-17-020070.md) | [328](/filings/0001144204-18-017279.md) | [343](/filings/0001144204-18-017279.md) | [394](/filings/0001104659-20-037959.md) | [387](/filings/0001104659-21-044259.md) | [425](/filings/0001410578-22-000463.md) | [731](/filings/0001410578-23-000618.md) | [808](/filings/0001104659-24-042156.md) | [780](/filings/0001410578-25-000623.md) | [743](/filings/0001104659-26-035507.md) | [833](/filings/0001104659-26-035507.md) |
| Short-term borrowings | $m | [130](/filings/0001144204-16-093972.md) | [180](/filings/0001144204-17-020070.md) | [138](/filings/0001144204-18-017279.md) | [147](/filings/0001144204-18-017279.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [473](/filings/0001144204-16-093972.md) | [439](/filings/0001144204-17-020070.md) | [468](/filings/0001144204-18-017279.md) | [457](/filings/0001144204-18-017279.md) | [447](/filings/0001104659-20-037959.md) | [433](/filings/0001104659-21-044259.md) | [480](/filings/0001410578-22-000463.md) | [870](/filings/0001410578-23-000618.md) | [893](/filings/0001104659-24-042156.md) | [857](/filings/0001410578-25-000623.md) | [890](/filings/0001104659-26-035507.md) | [893](/filings/0001104659-26-035507.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, ifrs-full:CashAndCashEquivalents
- Current assets: us-gaap:AssetsCurrent, ifrs-full:CurrentAssets
- Total assets: us-gaap:Assets, ifrs-full:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent, ifrs-full:CurrentLiabilities
- Total liabilities: us-gaap:Liabilities, ifrs-full:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 348,851,828 at 2025-12-31, from the cover of the [20-F filed 2026-03-27](/filings/0001104659-26-035507.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.